The porphyrias, a group of disorders characterized by abnormalities in the biosynthesis of haem, are classified in Table 1 (Goldberg et al., 1977) . They are errors of metabolism, mainly inborn, which involve specific enzymes in the haem biosynthetic Fig.) . The enzymes deficient in acute intermittent porphyria and erythropoetic protoporphyria have been identified as porphobilinogen deaminase (Meyer et al., 1972) and ferrochelatase (Bottomley et al., 1975) respectively. Brodie et al. (1976) have shown a reduction in coproporphyrinogen oxidase activity in hereditary coproporphyria. The defects in the other types of porphyria await delineation. The major sites of abnormal porphyrin production are liver and bone marrow, though haem biosynthesis is a function of every somatic cell. Control of the pathway is via feedback repression and inhibition by haem of 8-aminolaevulinic acid synthase, the first and rate-limiting enzyme in haem biosynthesis. Thus, common to all porphyrias is the finding of increased activity of this enzyme.
Received 13 January 1977
The acute porphyrias ( (Goldberg et al., 1977) . These diseases rarely present before puberty, and porphyria in childhood has been reviewed by Chisolm (1964) .
Hereditary coproporphyria is the least common of the acute porphyrias and is distinguished by excess faecal and often urinary excretion of coproporphyrin in remission and in the latent case. In the acute attack there is also increased urinary excretion of ALA and PBG. Hereditary coproporphyria was first described in a 10-year-old boy (Berger and Goldberg, 1955) and was for a time considered an asymptomatic biochemical abnormality. This is now known to be incorrect and cases have been reported associated with gastrointestinal symptoms (Goldberg et al., 1967; Haeger-Aronsen et al., 1968) , skin photosensitivity (Hunter et al., 1971; Jaeger et al., 1975) , psychiatric symptoms (Goldberg et al., 1967; McIntyre et al., 1971) , seizures (Birchfield and Cowger, 1966; Haeger-Aronsen et al., 1968) , and peripheral neuropathy (Dean et al., 1969; McIntyre et al., 1971) . Death from respiratory paralysis has occurred in 2 patients (Dean et al., 1969; Jaeger et al., 1975) . 8 children have been reported with biochemical findings of hereditary coproporphyria (Berger and Goldberg, 1955; Birchfield and Cowger, 1966; Goldberg et al., 1967; Haeger-Aronsen et al., 1968; Lomholt and With, 1969; Hunter et al., 1971; Jaeger et al., 1975) , but only 2 of them have had symptoms (Birchfield and Cowger, 1966; HaegerAronsen et al., 1968 
Results
The values for porphyrin and porphyrin precursor excretion in the patient and his family are given in Table 2 . The father and 2 sibs had normal porphyrin excretion, but the mother excreted increased amounts of faecal coproporphyrin. At the time of his acute attack prophyrin and porphyrin precursor levels were greatly increased in our patient and this was associated with increased activity of leucocyte ALA synthase, the mitochondrial rate-limiting enzyme of haem biosynthesis. In addition, no detectable activity of leucocyte coproporphyrinogen oxidase was observed. Similar increased ALA synthase activity and depression of coproporphyrinogen oxidase activity were found in the patient's mother, confirming that she is a latent case of the disease (Table 3) .
Discussion
The pathway of haem biosynthesis is outlined in the Fig. In hereditary coproporphyria increased activity of the initial mitochondrial rate-limiting enzyme of haem biosynthesis, ALA synthase, has previously been shown in the liver (Sasaki et al., 1969; Kaufman and Marver, 1970; McIntyre et al., 1971 ). In our study a similar increased activity has been found in the leucocytes. It has long been suspected and recently confirmed (Brodie et al., 1976 ) that a defined depression of coproporphyrinogen oxidase, the penultimate enzyme in the pathway, led to the excess excretion of coproporphyrin in this disease. Such a depression has clearly been shown in the leucocytes of the 2 patients studied. The increased ALA synthase activity may therefore be due to depressed levels of circulating free haem brought about by reduced coproporphyrinogen oxidase activity. This case is unusual in that the diagnosis of porphyria was suspected when the patient developed gastrointestinal symptoms similar to those of an acute porphyric attack but the biochemical findings excluded acute porphyria as the cause of the episode. Indeed, had the urine been tested only in the ward side room with Ehrlich's aldehyde reagent, the diagnosis would have been missed. This emphasizes the point made by Gatfield et al. (1972) that though it is common practice to test qualitatively for PBG in urine in the side room, it is also necessary to look for ALA and porphyrins if some cases of porphyria are not to be missed. Moreover, in hereditary coproporphyria raised faecal coproporphyrin may be the only abnormality, and complete quantitative analysis of urine and stool for porphyrins and precursors (Rimington, 1971) (Wetterberg, 1976) . Our patient had received phenobarbitone, phenytoin, meprobamate, and most recently primidone. The 2 children previously reported as having symptomatic hereditary coproporphyria (Birchfield and Cowger, 1966; Haeger-Aronsen et al., 1968) were also on anticonvulsants at the time of diagnosis. Birchfield's patient shows some similarity to ours (Table 4 (Goldberg and Rimington, 1962) , but the association of chronic epilepsy with porphyria is not well documented. Magnussen et al. (1975) reported a case of acute intermittent porphyria with long-standing grand mal seizures and discussed a possible relationship. We are aware of a further case in an institutionalized patient with mental retardation who developed intractable idiopathic epilepsy at the age of 3 years and in whom the diagnosis of porphyria was made at the age of 29. As in the present case, acquired skills were lost. We wish to stress the importance of considering the diagnosis of acute porphyria in any child with unexplained refractory epilepsy, especially when there are multiple seizure types suggestive of organic brain disorder, 'epileptic encephalopathy' with slow spike-wave on EEG (Chevrie and Aicardi, 1972) , or episodes of minor epileptic status (Brett, 1966) .
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